The Tuberculosis Drug Accelerator at year 10: what have we learned?

The Tuberculosis Drug Accelerator, an experiment designed to facilitate collaboration in tuberculosis drug discovery by breaking down barriers among competing labs and institutions, has reached a 10-year landmark. We review the consortium's achievements, advantages and limitations and advocate for the application of similar models to other diseases.

Automated summary

The Tuberculosis Drug Accelerator has successfully facilitated collaboration in tuberculosis drug discovery, breaking down barriers among competing labs and institutions. The achievements, advantages, and limitations of the consortium suggest that similar models could be applied to research on other diseases.